Author Affiliations: Dermatology Section, Department Internal Medicine, Northeast Ohio Medical University, Rootstown (Drs Brodell and Mostow); Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, Ohio (Drs Brodell and Mostow); and Department of Dermatology, University of Rochester School of Medicine and Dentistry, Rochester, New York (Dr Brodell). Mr Amarnani is a medical student at Northeast Ohio Medical University. Dr Brodell is now with the Division of Dermatology, University of Mississippi, Jackson, and Department of Dermatology, University of Rochester School of Medicine and Dentistry, Rochester.
Medical research and knowledge continues to expand at an unprecedented pace. This explosion of new information will undoubtedly improve our understanding of disease processes and the subsequent care we afford our patients. The volume of new information, however, poses its own unique obstacles—first and foremost is determining how to most efficiently access this information. Accessing available published literature is by no means a new problem and was highlighted by the tragic death of a Johns Hopkins University research volunteer following the inhalation of hexamethonium in 2001. It was later revealed that the investigators had failed to identify published literature about the known association between hexamethonium and lung toxicity.1
Amarnani A, Brodell RT, Mostow EN. Finding the Evidence With Eponyms. JAMA Dermatol. 2013;149(6):664–665. doi:10.1001/2013.jamadermatol.421